The use of lidocaine as a test of liver function in liver transplantation

scientific article

The use of lidocaine as a test of liver function in liver transplantation is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/LT.500020307
P698PubMed publication ID9346651
P5875ResearchGate publication ID13881789

P2093author name stringM Oellerich
J M Potter
P2860cites workThe immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450Q34421122
Assessment of the (14C) aminopyrine breath test in liver diseaseQ34473764
Influence of selected patient variables and operative blood loss on six-month survival following liver transplantationQ34498280
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patientsQ34567114
Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolitesQ37713715
Clinical Pharmacokinetics of LignocaineQ39725309
Quantitative Assessment of Deranged Hepatic Function: A Missed Opportunity?Q40164732
Evidence for pre-hepatic metabolism of oral cyclosporine in childrenQ42081648
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injuryQ42574211
Selection criteria for liver transplant donorsQ43808170
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.Q51659415
Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.Q51659423
Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver.Q51667347
Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX)Q51681773
Assessment of lidocaine metabolite formation as a quantitative liver function test in children.Q51727203
Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.Q51747037
Lignocaine metabolite formation as a measure of pre-transplant liver function.Q51755557
Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.Q55060683
P433issue3
P921main subjectlidocaineQ216935
P304page(s)211-224
P577publication date1996-05-01
P1433published inLiver TransplantationQ15730498
P1476titleThe use of lidocaine as a test of liver function in liver transplantation
P478volume2

Reverse relations

cites work (P2860)
Q46239194Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis
Q42796815Evaluating human liver reserve function by measuring serum concentrations of phenacetin and its metabolites
Q51495318Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans.
Q26741225Predictive factors of short term outcome after liver transplantation: A review
Q34109294The clinical importance of conventional and quantitative liver function tests in liver transplantation
Q49100561The lidocaine monoethylglycinexylidide test of liver function